Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.3045 EUR
950.09 M EUR
78.77 B EUR
1.34 B
About SINOPHARM GROUP CO. LTD.
Sector
Industry
Headquarters
Shanghai
Website
Founded
2003
ISIN
CNE100000FN7
FIGI
BBG000VZC5B0
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
The time to wake up the stock of giant Sinopharm is nearSinopharm Group is a profitable Chinese state company with 2 covid-19 vaccines (the first is approved in China) with very strong fundamentals (except debt).
Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend.
Next follows the stocks mid-ter
SinoPharma Elliott Wave estimate@HKex Start of Wave 3 with price estimates and time bounded by ellipse ;)
Health is wealth , agreed ?Some may not agree and that is fine !
Think for a moment. Many of us spent a lot of time working in our career, clocking hours after office hours hoping to gain that year end promotion, score that bonus or simply act out of peer pressure.
Take a minute to read this article I found.
I am of t
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where X2S is featured.
Related stocks
Frequently Asked Questions
The current price of X2S is 1.9590 EUR — it has decreased by −1.11% in the past 24 hours. Watch SINOPHARM GRP CO. H YC 1 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SINOPHARM GRP CO. H YC 1 stocks are traded under the ticker X2S.
X2S stock has fallen by −6.13% compared to the previous week, the month change is a −15.60% fall, over the last year SINOPHARM GRP CO. H YC 1 has showed a −16.71% decrease.
We've gathered analysts' opinions on SINOPHARM GRP CO. H YC 1 future price: according to them, X2S price has a max estimate of 3.15 EUR and a min estimate of 1.93 EUR. Watch X2S chart and read a more detailed SINOPHARM GRP CO. H YC 1 stock forecast: see what analysts think of SINOPHARM GRP CO. H YC 1 and suggest that you do with its stocks.
X2S stock is 1.28% volatile and has beta coefficient of 0.75. Track SINOPHARM GRP CO. H YC 1 stock price on the chart and check out the list of the most volatile stocks — is SINOPHARM GRP CO. H YC 1 there?
Today SINOPHARM GRP CO. H YC 1 has the market capitalization of 6.28 B, it has decreased by −0.77% over the last week.
Yes, you can track SINOPHARM GRP CO. H YC 1 financials in yearly and quarterly reports right on TradingView.
SINOPHARM GRP CO. H YC 1 is going to release the next earnings report on Sep 1, 2025. Keep track of upcoming events with our Earnings Calendar.
X2S earnings for the last half-year are 0.14 EUR per share, whereas the estimation was 0.19 EUR, resulting in a −24.11% surprise. The estimated earnings for the next half-year are 0.14 EUR per share. See more details about SINOPHARM GRP CO. H YC 1 earnings.
SINOPHARM GRP CO. H YC 1 revenue for the last half-year amounts to 38.34 B EUR, despite the estimated figure of 39.08 B EUR. In the next half-year revenue is expected to reach 36.50 B EUR.
X2S net income for the last half-year is 451.16 M EUR, while the previous report showed 479.74 M EUR of net income which accounts for −5.96% change. Track more SINOPHARM GRP CO. H YC 1 financial stats to get the full picture.
Yes, X2S dividends are paid annually. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 5.38%. Tracking SINOPHARM GRP CO. H YC 1 dividends might help you take more informed decisions.
SINOPHARM GRP CO. H YC 1 dividend yield was 3.40% in 2024, and payout ratio reached 29.54%. The year before the numbers were 4.67% and 29.82% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 20, 2025, the company has 108.22 K employees. See our rating of the largest employees — is SINOPHARM GRP CO. H YC 1 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINOPHARM GRP CO. H YC 1 EBITDA is 2.97 B EUR, and current EBITDA margin is 3.77%. See more stats in SINOPHARM GRP CO. H YC 1 financial statements.
Like other stocks, X2S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINOPHARM GRP CO. H YC 1 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINOPHARM GRP CO. H YC 1 technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINOPHARM GRP CO. H YC 1 stock shows the strong sell signal. See more of SINOPHARM GRP CO. H YC 1 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.